Beta Bionics, Inc. (BBNX) PT Raised to $19 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BBNX Hot Sheet
Price: $22.04 --0%
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 5 | New: 31
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 5 | New: 31
Join SI Premium – FREE
Goldman Sachs analyst David Roman raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $19.00 (from $17.00) while maintaining a Buy rating.
You May Also Be Interested In
- Beta Bionics to integrate iLet system with Senseonics' Eversense 365 CGM
- PTC Therapeutics (PTCT) PT Raised to $137 at Cantor Fitzgerald on ST-920 Acquisition
- Trigano SA (TRI:FP) PT Lowered to EUR165 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
